非洲乙型肝炎血清流行病学:基于系统综述与荟萃分析的干预策略建模
该研究通过系统综述与荟萃分析汇总1995—2019年非洲39国96项成人血清流行病学数据,发现HBsAg与anti-HBc流行率呈强相关(R2=0.45,p<0.001),北部非洲CHB患病率较南部非洲低30%—40%(p=0.007)。数学建模显示检测治疗策略在高流行区20年可降33%流行率(95%CI 30%—37%),50年降62%(95%CI 57%—68%),优于成人补种疫苗。
要点
- 非洲HBV感染与暴露流行率强相关,区域差异显著需本地化干预。
- 检测治疗策略在高流行区长期效果最显著,成人补种疫苗效果短暂微弱。
- 新生儿常规免疫与PMTCT是基础,检测治疗可加速消除目标。
核心结论
- 在非洲高流行区,检测治疗策略对降低HBV总体流行率效果最显著且持久,成人补种疫苗影响微弱短暂。
研究设计与样本
- 基于加权线性回归分析HBsAg与anti-HBc流行率关系,并应用已发表数学模型模拟高流行区干预效果。
主要发现
- HBsAg与anti-HBc流行率强相关(R2=0.45,p<0.001)。
- 统计相似暴露率下,北部非洲CHB患病率较南部非洲低30%—40%(p=0.007)。
- 检测治疗策略预测20年流行率降33%(95%CI 30%—37%),50年降62%(95%CI 57%—68%)。
- 成人补种疫苗对人群流行率影响可忽略且短暂。
临床怎么用
- 在非洲高流行区,应将检测治疗作为核心干预策略与新生儿免疫、PMTCT及高危人群接种结合推进消除目标。
- 干预策略需根据区域流行病学差异本地化调整。
局限性
- 已发表数据存在缺口,无法按特定临床标准分层建模抗病毒治疗影响。
- 模型框架未纳入年龄特异性或风险组传播力假设。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: International Sustainable Development Goals (SDGs) for elimination of hepatitis B virus (HBV) infection set ambitious targets for 2030. In African populations, infant immunisation has been fundamental to reducing incident infections in children, but overall population prevalence of chronic hepatitis B (CHB) infection remains high. In high-prevalence populations, adult catch-up vaccination has sometimes been deployed, but an alternative Test and Treat (T&T) approach could be used as an intervention to interrupt transmission. Universal T&T has not been previously evaluated as a population intervention for HBV infection, despite high-profile data supporting its success with human immunodeficiency virus (HIV). METHODS AND FINDINGS: We set out to investigate the relationship between prevalence of HBV infection and exposure in Africa, undertaking a systematic literature review in November 2019. We identified published seroepidemiology data representing the period 1995-2019 from PubMed and Web of Science, including studies of adults that reported prevalence of both hepatitis B surface antigen (HBsAg; prevalence of HBV infection) and antibody to hepatitis B core antigen (anti-HBc; prevalence of HBV exposure). We identified 96 studies representing 39 African countries, with a median cohort size of 370 participants and a median participant age of 34 years. Using weighted linear regression analysis, we found a strong relationship between the prevalence of infection (HBsAg) and exposure (anti-HBc) (R2 = 0.45, p < 0.001). Region-specific differences were present, with estimated CHB prevalence in Northern Africa typically 30% to 40% lower (p = 0.007) than in Southern Africa for statistically similar exposure rates, demonstrating the need for intervention strategies to be tailored to individual settings. We applied a previously published mathematical model to investigate the effect of interventions in a high-prevalence setting. The most marked and sustained impact was projected with a T&T strategy, with a predicted reduction of 33% prevalence by 20 years (95% CI 30%-37%) and 62% at 50 years (95% CI 57%-68%), followed by routine neonatal vaccination and prevention of mother to child transmission (PMTCT; at 100% coverage). In contrast, the impact of catch-up vaccination in adults had a negligible and transient effect on population prevalence. The study is constrained by gaps in the published data, such that we could not model the impact of antiviral therapy based on stratification by specific clinical criteria and our model framework does not include explicit age-specific or risk-group assumptions regarding force of transmission. CONCLUSIONS: The unique data set collected in this study highlights how regional epidemiology data for HBV can provide insights into patterns of transmission, and it provides an evidence base for future quantitative research into the most effective local interventions. In combination with robust neonatal immunisation programmes, ongoing PMTCT efforts, and the vaccination of high-risk groups, diagnosing and treating HBV infection is likely to be of most impact in driving advances towards elimination targets at a population level.
引用
- McNaughton AL, Lourenço J, Bester PA, et al. Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis. PLoS Med. 2020. PMID: 32315297. doi:10.1371/journal.pmed.1003068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。